Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot2: STU1 Ballot 2) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions

: Standard care Group in Adults with type 2 diabetes with moderate CV risk - JSON Representation

Page standards status: Informative

Raw json | Download

{
  "resourceType" : "Group",
  "id" : "236534",
  "meta" : {
    "versionId" : "67",
    "lastUpdated" : "2025-03-20T18:40:09.616Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/comparator-group"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Group 236534</b></p><a name=\"236534\"> </a><a name=\"hc236534\"> </a><a name=\"236534-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 67; Last updated: 2025-03-20 18:40:09+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-comparator-group.html\">ComparatorGroup</a></p></div><p><b>Artifact Author</b>: Computable Publishing®: MAGIC-to-FEvIR Converter: </p><blockquote><p><b>RelatesTo</b></p><ul><li>type: part-of</li><li>targetReference: MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)</li></ul></blockquote><p><b>url</b>: <a href=\"https://fevir.net/resources/Group/236534\">https://fevir.net/resources/Group/236534</a></p><p><b>identifier</b>: FEvIR Object Identifier/https://fevir.net/FOI/236534, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-comparator-group-MAGIC-5288-j1Wqrn-comparator-85390-C-85789</p><p><b>title</b>: Standard care Group in Adults with type 2 diabetes with moderate CV risk</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>Standard care</p>\n</div><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication</a>: Evidence Communication</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ComparatorGroup}\">ComparatorGroup</span></td></tr></table><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>type</b>: Person</p><p><b>membership</b>: Enumerated</p><p><b>combinationMethod</b>: All of</p><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Member of</span></p><p><b>value</b>: <a href=\"Group-236533.html\">Adults with type 2 diabetes and established CVD (but no CKD)</a></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>inclusion in Adults with type 2 diabetes with moderate CV risk</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Exposed to</span></p><p><b>value</b>: <a href=\"Group-236530.html\">Standard care</a></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>received Standard care</p>\n</div></blockquote></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail" : {
        "name" : "Computable Publishing®: MAGIC-to-FEvIR Converter"
      }
    },
    {
      "extension" : [
        {
          "url" : "type",
          "valueCode" : "part-of"
        },
        {
          "url" : "targetReference",
          "valueReference" : {
            "type" : "Composition",
            "identifier" : {
              "type" : {
                "text" : "FEvIR Linking Identifier"
              },
              "system" : "https://fevir.net/FLI",
              "value" : "MAGIC-5288-j1Wqrn-conversion-report",
              "assigner" : {
                "display" : "Computable Publishing LLC"
              }
            },
            "display" : "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"
          }
        }
      ],
      "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/relates-to"
    }
  ],
  "url" : "https://fevir.net/resources/Group/236534",
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "urn:ietf:rfc:3986",
      "value" : "https://fevir.net/FOI/236534",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    },
    {
      "type" : {
        "text" : "FEvIR Linking Identifier"
      },
      "system" : "https://fevir.net/FLI",
      "value" : "MAGIC-5288-j1Wqrn-comparator-group-MAGIC-5288-j1Wqrn-comparator-85390-C-85789",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "title" : "Standard care Group in Adults with type 2 diabetes with moderate CV risk",
  "status" : "active",
  "publisher" : "Computable Publishing LLC",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "email",
          "value" : "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description" : "Standard care",
  "useContext" : [
    {
      "code" : {
        "system" : "https://fevir.net/resources/CodeSystem/179423",
        "code" : "evidence-communication",
        "display" : "Evidence Communication"
      },
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "https://fevir.net/resources/CodeSystem/179423",
            "code" : "ComparatorGroup",
            "display" : "ComparatorGroup"
          }
        ]
      }
    }
  ],
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "type" : "person",
  "membership" : "enumerated",
  "combinationMethod" : "all-of",
  "characteristic" : [
    {
      "code" : {
        "text" : "Member of"
      },
      "valueReference" : {
        🔗 "reference" : "Group/236533",
        "type" : "Group",
        "identifier" : {
          "type" : {
            "text" : "FEvIR Linking Identifier"
          },
          "system" : "https://fevir.net/FLI",
          "value" : "MAGIC-5288-j1Wqrn-population-group-85390-85789",
          "assigner" : {
            "display" : "Computable Publishing LLC"
          }
        },
        "display" : "Adults with type 2 diabetes and established CVD (but no CKD)"
      },
      "exclude" : false,
      "description" : "inclusion in Adults with type 2 diabetes with moderate CV risk"
    },
    {
      "code" : {
        "text" : "Exposed to"
      },
      "valueReference" : {
        🔗 "reference" : "Group/236530",
        "type" : "Group",
        "identifier" : {
          "type" : {
            "text" : "FEvIR Linking Identifier"
          },
          "system" : "https://fevir.net/FLI",
          "value" : "MAGIC-5288-j1Wqrn-comparator-85390-C-85789",
          "assigner" : {
            "display" : "Computable Publishing LLC"
          }
        },
        "display" : "Standard care"
      },
      "exclude" : false,
      "description" : "received Standard care"
    }
  ]
}